Cargando…

Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — The ATTRACTIVE-TTAS study

INTRODUCTION: Bleeding complications after transcatheter aortic valve implantation (TAVI) is a major problem in clinical practice. However, there is few information on thrombogenicity after TAVI. The aim of this study was to establish a monitoring of total thrombogenicity in perioperative TAVI using...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Masanobu, Kaikita, Koichi, Mitsuse, Tatsuro, Nakanishi, Nobuhiro, Oimatsu, Yu, Yamashita, Takayoshi, Nagamatsu, Suguru, Tabata, Noriaki, Fujisue, Koichiro, Sueta, Daisuke, Takashio, Seiji, Arima, Yuichiro, Sakamoto, Kenji, Yamamoto, Eiichiro, Tsujita, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441766/
https://www.ncbi.nlm.nih.gov/pubmed/30976651
http://dx.doi.org/10.1016/j.ijcha.2019.100346
_version_ 1783407594735403008
author Ishii, Masanobu
Kaikita, Koichi
Mitsuse, Tatsuro
Nakanishi, Nobuhiro
Oimatsu, Yu
Yamashita, Takayoshi
Nagamatsu, Suguru
Tabata, Noriaki
Fujisue, Koichiro
Sueta, Daisuke
Takashio, Seiji
Arima, Yuichiro
Sakamoto, Kenji
Yamamoto, Eiichiro
Tsujita, Kenichi
author_facet Ishii, Masanobu
Kaikita, Koichi
Mitsuse, Tatsuro
Nakanishi, Nobuhiro
Oimatsu, Yu
Yamashita, Takayoshi
Nagamatsu, Suguru
Tabata, Noriaki
Fujisue, Koichiro
Sueta, Daisuke
Takashio, Seiji
Arima, Yuichiro
Sakamoto, Kenji
Yamamoto, Eiichiro
Tsujita, Kenichi
author_sort Ishii, Masanobu
collection PubMed
description INTRODUCTION: Bleeding complications after transcatheter aortic valve implantation (TAVI) is a major problem in clinical practice. However, there is few information on thrombogenicity after TAVI. The aim of this study was to establish a monitoring of total thrombogenicity in perioperative TAVI using the Total Thrombus-formation Analysis System (T-TAS), a microchip-based flow chamber system for analysis of thrombus formation under flow condition. METHODS: Twenty-three patients with severe aortic stenosis who underwent TAVI between August 2017 and March 2018 at Kumamoto university hospital were enrolled. After exclusion, data of 21 patients were analyzed. Blood samples were obtained before, 2, 7, and 30 days after TAVI. Thrombogenicity were assessed by the T-TAS to compute the area under the curve (AUC) (AR(10)-AUC(30)) in the AR chip. We also measured platelet count, high-molecular-weight von Willebrand factor (HMW-vWF) multimers, and plasma thrombopoietin. Computational fluid dynamics (CFD) analysis was performed to calculate the wall shear stress (WSS). RESULTS: The AR(10)-AUC(30) levels and platelet counts were significantly lower at 2 days post-TAVI, and then increased gradually. HMW-vWF multimers, and plasma thrombopoietin, were significantly higher at 2 days post-TAVI, compared with before TAVI. CFD analysis showed that WSS of the aortic valve and posterior ascending aortic wall were significantly lower after TAVI than before-TAVI. Multivariate analysis identified max velocity measured by echocardiography, platelet count, and D-dimer as significant determinants of AR(10)-AUC(30), representing total thrombogenicity. CONCLUSIONS: Although HMW-vWF multimers improved earlier after TAVI, total thrombogenic activity evaluated by T-TAS remained relatively low followed by improvement in thrombogenic activity at 30 days after TAVI. Clinical Trial Registration: https://clinicaltrials.gov. Unique identifiers: NCT03248232.
format Online
Article
Text
id pubmed-6441766
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-64417662019-04-11 Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — The ATTRACTIVE-TTAS study Ishii, Masanobu Kaikita, Koichi Mitsuse, Tatsuro Nakanishi, Nobuhiro Oimatsu, Yu Yamashita, Takayoshi Nagamatsu, Suguru Tabata, Noriaki Fujisue, Koichiro Sueta, Daisuke Takashio, Seiji Arima, Yuichiro Sakamoto, Kenji Yamamoto, Eiichiro Tsujita, Kenichi Int J Cardiol Heart Vasc Original Paper INTRODUCTION: Bleeding complications after transcatheter aortic valve implantation (TAVI) is a major problem in clinical practice. However, there is few information on thrombogenicity after TAVI. The aim of this study was to establish a monitoring of total thrombogenicity in perioperative TAVI using the Total Thrombus-formation Analysis System (T-TAS), a microchip-based flow chamber system for analysis of thrombus formation under flow condition. METHODS: Twenty-three patients with severe aortic stenosis who underwent TAVI between August 2017 and March 2018 at Kumamoto university hospital were enrolled. After exclusion, data of 21 patients were analyzed. Blood samples were obtained before, 2, 7, and 30 days after TAVI. Thrombogenicity were assessed by the T-TAS to compute the area under the curve (AUC) (AR(10)-AUC(30)) in the AR chip. We also measured platelet count, high-molecular-weight von Willebrand factor (HMW-vWF) multimers, and plasma thrombopoietin. Computational fluid dynamics (CFD) analysis was performed to calculate the wall shear stress (WSS). RESULTS: The AR(10)-AUC(30) levels and platelet counts were significantly lower at 2 days post-TAVI, and then increased gradually. HMW-vWF multimers, and plasma thrombopoietin, were significantly higher at 2 days post-TAVI, compared with before TAVI. CFD analysis showed that WSS of the aortic valve and posterior ascending aortic wall were significantly lower after TAVI than before-TAVI. Multivariate analysis identified max velocity measured by echocardiography, platelet count, and D-dimer as significant determinants of AR(10)-AUC(30), representing total thrombogenicity. CONCLUSIONS: Although HMW-vWF multimers improved earlier after TAVI, total thrombogenic activity evaluated by T-TAS remained relatively low followed by improvement in thrombogenic activity at 30 days after TAVI. Clinical Trial Registration: https://clinicaltrials.gov. Unique identifiers: NCT03248232. Elsevier 2019-03-28 /pmc/articles/PMC6441766/ /pubmed/30976651 http://dx.doi.org/10.1016/j.ijcha.2019.100346 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Paper
Ishii, Masanobu
Kaikita, Koichi
Mitsuse, Tatsuro
Nakanishi, Nobuhiro
Oimatsu, Yu
Yamashita, Takayoshi
Nagamatsu, Suguru
Tabata, Noriaki
Fujisue, Koichiro
Sueta, Daisuke
Takashio, Seiji
Arima, Yuichiro
Sakamoto, Kenji
Yamamoto, Eiichiro
Tsujita, Kenichi
Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — The ATTRACTIVE-TTAS study
title Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — The ATTRACTIVE-TTAS study
title_full Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — The ATTRACTIVE-TTAS study
title_fullStr Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — The ATTRACTIVE-TTAS study
title_full_unstemmed Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — The ATTRACTIVE-TTAS study
title_short Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — The ATTRACTIVE-TTAS study
title_sort reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — the attractive-ttas study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441766/
https://www.ncbi.nlm.nih.gov/pubmed/30976651
http://dx.doi.org/10.1016/j.ijcha.2019.100346
work_keys_str_mv AT ishiimasanobu reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT kaikitakoichi reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT mitsusetatsuro reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT nakanishinobuhiro reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT oimatsuyu reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT yamashitatakayoshi reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT nagamatsusuguru reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT tabatanoriaki reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT fujisuekoichiro reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT suetadaisuke reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT takashioseiji reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT arimayuichiro reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT sakamotokenji reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT yamamotoeiichiro reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy
AT tsujitakenichi reductioninthrombogenicactivityandthrombocytopeniaaftertranscatheteraorticvalveimplantationtheattractivettasstudy